Clinical Study of Shirishadi tablet in the management of Tamaka Shvasa w.s.r. to Bronchial Asthma

Author(s):  
Pankaj Chhayani ◽  
Hemang Raghavani ◽  
Dhananjay Patel

Tamaka Shvasa is described as a most difficult to cure (Yapya) among all diseases in Ayurveda. In present study Tamaka Shvasa is correlated with Bronchial Asthma because of its symptomatology is much similar with Tamaka Shvasa. In modern medical science, steroids and bronchodilators are mainly used for its management, but they cause certain side effects. Present study was undertaken to provide safe and effective remedy for Tamaka Shvasa through Ayurvedic medicaments. Shirishadi tablet was given as internal medicine for 30 days. Upto 60% relief was found in signs and symptoms of Tamaka Shvasa.

2020 ◽  
Vol 8 (10) ◽  
pp. 4894-4901
Author(s):  
Momin Jasmin Begam ◽  
Kulkarni Prasad ◽  
Gogate Vishwas

Bronchial asthma is a heterogenous disease with reciprocity between genetic and environmental factors. The different triggering factors increase the frequency and severity of breathing difficulty attacks. The use of modern medicines is restricted due to its various local as well systemic side effects. The clinical picture of bronchial asthma can be correlated with Tamakashwas as explained in Ayurveda. In the present case study, a 24 years old female patient having signs and symptoms of Tamakashwas has been discussed. The treatment was administered in accordance with Shodhana Chikitsa, Shamana Aushadhis and Sthanika Chikitsa. Nidana Parivarjana is strictly instructed in order to avoid the stimulation to internal pathology of the disease. The classical management helps in relieving the symptoms as well as lowers the recurrence of the breathing difficulty attacks. Regular counselling and practice of Parnayama contributes in boosting and refreshing her mind. The assessment was done by using the gradation scale which was adopted from de-veloping guidelines for clinical research methodology in Ayurveda. This Ayurvedic management helps in achieving the positive output with complete stoppage of use of inhaler over a period of 6 months.


Author(s):  
Athira.C ◽  
Ajay Bhat U

Gridhrasi is a Vyadhi characterized by Stambha (stiffness), Ruk (pain), Toda (pricking pain), Spandana (twitching) etc. Though it is of two types – Vataja and Vatakaphaja, Vata being the prime cause for this condition has to be tackled to gain relief. Gridhrasi, according to its signs and symptoms can be compared to sciatica in modern medical science which is a painful condition in which pain commences from the buttock and radiates into the lower extremity along its posterior or lateral aspect, more or less comprising of the area of distribution of the sciatic nerve. Thus, this study was taken up to evaluate the efficacy of Rasona taila and Gandharvahastadi eranda taila in the management of Gridhrasi (Sciatica). Methods: In the present study, 60 subjects diagnosed with Gridhrasi were randomly selected and assigned into two equal groups Group A and Group B comprising 30 subjects each. Subjects of Group A received Rasona taila 10ml orally in morning before food and subjects of Group B received Gandharvahastadi eranda taila 10 ml orally in morning before food, both for duration of 21 days. The data obtained in both the groups were recorded, tabulated and statistically analyzed using appropriate statistical methods. Results: After obtaining all the necessary data, the results were formulated by applying suitable statistical tests. Group A showed better results statistically when compared to Group B. Conclusion: Rasona taila has better effects than Gandharvahastadi eranda taila both clinically and statistically in reducing the signs and symptoms of Gridhrasi.


AYUSHDHARA ◽  
2021 ◽  
pp. 3270-3275
Author(s):  
Gulhane Harshad ◽  
Bhople Sunanda ◽  
Sangita Vidhale ◽  
Anjali Deshmukh ◽  
Anup Pande

The disease Amavata described in classical Ayurvedic literature is closely mimic with Rheumatoid Arthritis (RA) in modern medical science. Amavata is the challenging problem for medical science with different treatment protocol. In this clinical study 15 patients were included having typical symptoms. All the included patients treated with Vaitaran Basti (medicated enema) to evaluate its efficacy in said disease. The patients were diagnosed on the basis of American criteria of Rheumatoid Arthritis as well as signs and symptoms mentioned in the classics. Aim: To assess the efficacy of Vaitaran Basti in the patients of Amavata, reveal the probable action of Vaitarana Basti in the management of Amavata. Materials and Methods: In the present study 15 patients of Amavata were studied. These patients were selected irrespective of sex, religion and economical status. The patients were diagnosed on the basis of American criteria of Rheumatoid Arthritis as well as signs and symptoms mentioned in the classics. American is mentioned criteria of Rheumatoid. Result: Paired t test was applied to this BT and AT scores as these grades are accepted as per international norms. It showed that administered therapy reduced degree of disease activity significantly as P < 0.001. Conclusion: It showed that administered therapy reduced degree of disease activity significantly as P < 0.001.


Author(s):  
Sangeeta . ◽  
Rajendra Prasad ◽  
V. K. Srivastava

Ayurveda is the science of life which deals with the prevention and cure of diseases. From the first breath of newly born till the last breath i.e, Shwasochhwasa Kriya is the sign of life. Any disturbance in this process leads to Shwasa Roga. Tamaka Shwasa is one of the important diseases of such disturbance. Shwasa is a Kapha-Vataja disease which is originated from Pittasthana. Tamaka Shwasa is very much similar to bronchial asthma in modern medicine which is a chronic disease of multifactorial origin. Ayurveda describes two type of management of all disease i.e. Shodhana and Shamana Chikitsa. In present scenario Panchakarma therapy is the best way to effectively and safely manage the condition without any specific side effects. It is one of the most effective and complete therapy in the management of the chronic disease such as Tamaka Shwasa (Bronchial Asthma). In Ayurvedic classics both Vamana and Virechana have been described specifically in the management of Tamaka Shwasa. Considering the Ayurvedic concept of treatment of Tamaka Shwasa, in present study we have used Virechana therapy along with certain herbal preparation. In this study we concluded that the cases who were treated with herbal preparation along with Virechana got better relief than herbal preparation alone.


Author(s):  
Apila Nath M.K ◽  
N.Sudhakar ◽  
Sarojini Byadagi ◽  
Binu.M.B

Stanya Kshaya is a common threat, especially with primiparous women and the incidence had been estimated to range from 23% to 63 % during the first 4 months after delivery. Emotional stress, anxiety and maternal illness are the various psychosomatic factors that influence the production of milk. A total 30 patients who fulfilled the inclusion criteria were selected randomly selected. Haridradi Gana Kwatha, 48ml, two times a day, after food for a period of 30 days was given. They were followed up every 10th day for 40 days after intervention. Initially all were noted and changes in signs and symptoms in each follow up were observed and noted. Comparing all parameters, before treatment and after treatment the study revealed extremely statistically significant. Haridradi Gana kwatha has promising results in the management of all the parameters of Stanya Kshaya. Haridradi Gana kwatha has promising results in the management of all the parameters of Stanya Kshaya. Mandagni serving as Nidana of all diseases is corrected by the judicial usage of drugs which are having Deepaniya Pachana Guna. The correction of Atisantarpana leads to normalisation of Vata also. Hence the Preenana from the diet is assimilated properly by the Jatharagni.


2021 ◽  
Vol p5 (02) ◽  
pp. 2705-2713
Author(s):  
Nishu Raina

Asthma is a chronic inflammatory disease which causes the lining of the airways to become swollen and inflamed, which further leads to production of thick, sticky mucous. These changes further cause the airways to become narrow, making it difficult for the patient to breathe properly. In this study, efficacy of formulations like Vasavaleha and Kantakari Avaleha are studied in the patients of Tamaka Shwasa w.s.r to bronchial asthma. Tamaka Shwasa is a Yapya Vyadhi. The etiopathogenesis, signs, and symptoms of Tamaka Shwasa may be correlated with Bronchial Asthma. Each patient reacts differently to the factors that trigger asthma and are treated symptomatically. Asthma is the most common chronic allergic disorder in childhood and third leading cause of hospitalization under the age of 15 years. As it is a Kapha-Vata predominant disorder, Ayurvedic medicine may help to decrease the recurrence, improve immunity, and check symptoms naturally. With this aim, a clinical study was undertaken on two groups for a duration of 6 weeks. The Kantakari Avaleha and Vasa Avaleha were given orally, separately in both the groups. All the patients were kept under strict dietary control during the treatment. The observation on the effect of therapy was encouraging and showed less recurrence.


Immunotherapy ◽  
2021 ◽  
Author(s):  
Thomas Bieber ◽  
Eric L Simpson ◽  
Jonathan I Silverberg ◽  
Diamant Thaçi ◽  
Carle Paul ◽  
...  

Atopic dermatitis (AD, also called atopic eczema) is a long-term skin disease that causes intensely itchy, red skin. Healthcare providers can prescribe medicated creams and ointments to reduce the signs and symptoms of AD. However, these treatments are not always enough to provide relief. A new medicine called abrocitinib, which is taken every day as a tablet, reduces part of the body’s immune response that happens in AD. The clinical study described in this plain language summary, called JADE COMPARE, investigated how well and how safely 16 weeks of treatment with abrocitinib worked in adults with AD compared to placebo (‘dummy treatment’) and a medicine that is already approved for AD, called dupilumab. The study showed that abrocitinib was better than placebo in improving the signs and symptoms of AD after 16 weeks. In addition, patients who were taking abrocitinib 200 mg for 2 weeks experienced greater relief from itch than patients who were taking abrocitinib 100 mg, placebo, or dupilumab. More people who took abrocitinib 200 mg reported side effects than those taking abrocitinib 100 mg, placebo, or dupilumab, but most of these side effects were mild or moderate.


Author(s):  
Lalita Gaonkar ◽  
Gururaja H ◽  
Jeejo Chandran O

In Ayurveda all the skin diseases are described under single heading i.e. ‘Kushta’ which are further divided into Mahakushta and Kshudrakushta. Vipadika is among the 11 types of Kshudra Kushta involving Vata Kapha mentioned in classics characterized by ‘Panipada Sphutana’ (Fissures in Palms and Soles) and ‘Tivravedana’ (Severe Pain). On basis of its signs and symptoms it can be correlated with ‘Palmoplantar Psoriasis’. Kushtachikitsa is classified into Shodhanam, Shamanam and Nidanparivarjana amongst which Shodhana Chikitsa is of greater significance in skin diseases, and Raktamokshana is considered to be a shortest and effective treatment in the management of skin diseases. Siravyadha is a type of Panchashodhana described by Acharya’s as an effective remedy in number of disease conditions. Acharya Sushruta and Vagbhata has mentioned that Siravyadha is half treatment in Shalyatantra as Basti is the half treatment in Kayachikitsa. Diseases which do not get pacified so quickly by therapeutic measures like Snehana, Swedana etc. are pacified by Siravyadha.


Author(s):  
Ankur Singhal ◽  
Komal Gupta

Gridhrasi is a painful condition in which the person can’t sit and walk properly that hampers his normal activity. Almost all signs and symptoms of Gridhrasi resemble with the condition of sciatica described by the modern texts. Its detail symptomatology has been described in Ayurvedic classics since 5000 years, while this condition was known to modern medical science just two centuries ago. According to Ayurveda principles treatment for Vatavyadhi should be Shodhana followed by Shamana therapy. According to present era it should be less time consuming and more effective. Keeping this in mind, A clinical study in the management of Gridhrasi with Shodhana and Shamana therapy was undertaken in VYDSAMC and Hospital, Khurja,Bulandshahr, with the aim to give promising results to the patient of Gridhrasi. Shodhana therapy as Mridu Virechana followed by Shamana with Yograja Guggulu and Maharasnadi Kwatha was given to 29 patients with classical symptoms of Gridhrasi, it showed significant results. The following study can be taken for further research in this field.


Author(s):  
Devanand E ◽  
K Ravindra Bhat

Ayurveda classics mentioned various types of Swasa and Tamaka Swasa is one among them. Tamakaswasa is manifested by aggravated Pranavayu by the obstruction of Kapha. In this case treatment should be to clear out Pranavaha srotas, pacify Vata and remove the blockage due to Kapha. In modern science Tamaka Swasa is correlated with Bronchial Asthma. It’s a chronic inflammatory disorder of the airways in which the chronic inflammation causes an associated increase in airway hyper responsiveness that leads to recurrent episodes of asthmatic exacerbation. Modern science has no permanent cure of Tamaka Swasa, that’s why it is necessity to search herbal and herbo-mineral preparations for the treatment of disease. Present Study was conducted to reduce the symptoms of Tamakaswasa. Bharangyadi Choorna and Vyaghri Choorna have the properties of Kapha Vata hara, Agni Deepana, Pachana, Anulomana, Srotoshodhana, anti-asthamatic and anti-inflammatory property. Materials and Method: Patients who have symptoms of Tamakaswasa fulfill the inclusion criteria were given with Bharangyadi Choorna 4gm thrice a day along with Ardraka Swarasa as Anupana in the trail group i.e., group A and Vyaghri Choorna 4gm thrice a day along with honey as Anupana in the control group i.e. group B. It is a comparative clinical study with 30 patients in each group for 30 days. Analyzing the signs and symptoms, PEFR after each 10 days, Wilcoxon test was done for comparing the effectiveness of treatment between two groups. Comparative analysis of the overall effect of the treatments in both the groups was done by statistically done by Mann-Whitney test. Results: There was statistically significant change in all the signs and symptoms and PEFR after treatment and follow up. All the signs and symptoms have P ≤ 0.05. Conclusion: Bharangyadi Choorna has shown highly significant reduction in the symptoms like Swasakrichratha, Peenasa, Kasa, Ghurghuraka, Krichrabhashana, Shushkasya and PEFR. On comparison between the two groups, Bharangyadi choorna showed a better result in improvement of symptoms- Swasakrichratha, Peenasa, Kasa, Ghurghuraka, Krichrabhashana, Shushkasya and objective parameter- PEFR. Hence H2 hold good.


Sign in / Sign up

Export Citation Format

Share Document